Challenges in CLL: Maximising each line of treatment
7 September 2021 - 47 Minutes

Challenges in CLL: Maximising each line of treatment



On behalf of the Scientific Committee, you are invited to join us for this LIVE interactive broadcast.

Professor Paolo Ghia, Professor Peter Hillmen and Dr George Follows will discuss why it is crucial to get the maximum benefit from each line of CLL treatment and how practical strategies can be applied to ensure that patients are managed appropriately to ...

more info...

EM-63879
Challenges in NHL: complications of Waldenström’s macroglobulinemia?
13 July 2021 - 59 Minutes

Challenges in NHL: complications of Waldenström’s macroglobulinemia?



On behalf of the Scientific Committee, you are invited to join us for this LIVE interactive broadcast.

Professor Christian Buske and Professor Steve Treon will discuss the clinical management of patients with Waldenström’s macroglobulinemia, including:

•    The implications of increased understanding of disease biology for treatment selection
•    The management of WM-associated complications such as neuropathy and amyloidosis
•    Strategies ...

more info...

EM-64268
COMy and EHA 2021: what's for my practice?
8 July 2021 - 51 Minutes

COMy and EHA 2021: what's for my practice?

Myeloma Connect 2021 is a series of live, interactive broadcasts, each focussed on a specific topic relevant to hematologists treating patients with multiple myeloma. The series (July to December 2021) will focus on key issues relating to the management of patients with multiple myeloma.

 

Learning objective:

After participating in this webinar, viewers should be able to:

  • ...

more info...

EM-56851
Challenges in CLL: Fixed duration therapies: where do they fit?
6 July 2021 - 48 Minutes

Challenges in CLL: Fixed duration therapies: where do they fit?



On behalf of the Scientific Committee, you are invited to join us for this LIVE interactive broadcast.

In light of recent data updates, Professor Paolo Ghia and Professor Peter Hillmen will discuss the potential role of fixed duration therapies in the management of CLL. In particular they will:

•    Consider which patients with CLL may benefit from a fixed duration approach
•    ...

more info...

EM-63877
Precision medicine in lymphoma: what does it mean?
2 July 2021 - 92 Minutes

Precision medicine in lymphoma: what does it mean?

On demand Janssen satellite symposium from the virtual iCML Congress 2021

Welcome and Introductions
John Gribben


Roundtable discussion: What does precision medicine mean for the management of lymphoma now and in the future?
  • Precision medicine in diagnosis and disease characterization
  • Precision medicine in biology-driven treatment
  • Precision medicine in response evaluation
  • The role of ...
more info...

EM-61411
Medication burden: When is enough enough?
29 June 2021 - 46 Minutes

Medication burden: When is enough enough?

Learning objective:

After participating in this broadcast you should be able to:

  • Discuss how to optimize the management of patients with multiple myeloma

 

Moderator:

  • Mohamad Mohty (France)

 

Faculty:

  • Rakesh Popat (UK)
more info...

EM-48512
Highlights from EHA and ICML 2021: Updates on the management of B-cell lymphomas
28 June 2021 - 62 Minutes

Highlights from EHA and ICML 2021: Updates on the management of B-cell lymphomas

Learning objective:

After participating in this webinar, viewers should be able to:

  • Consider how recent data updates may impact the clinical management of patients with B-cell lymphoma

 

Faculty:

  • Christian Buske (Germany)
  • Georg Hess (Germany)

 

more info...

EM-59305
Highlights from EHA 2021: expert insights and clinical implications for data on cell therapies in multiple myeloma
24 June 2021 - 62 Minutes

Highlights from EHA 2021: expert insights and clinical implications for data on cell therapies in multiple myeloma

Learning objective:

After participating in this webinar, viewers should be able to:

  • Discuss the potential role of cellular therapies in the management of patients with multiple myeloma 

 

Faculty:

  • Paula Rodriguez-Otero (Spain)
  • Niels van de Donk (The Netherlands)
  • Maria-Victoria Mateos (Spain)

 

more info...

EM-59303
Highlights from EHA 2021: A focus on chronic lymphocytic leukemia
23 June 2021 - 66 Minutes

Highlights from EHA 2021: A focus on chronic lymphocytic leukemia

Learning objective:

After participating in this webinar, viewers should be able to:

  • Evaluate how recent data updates may impact the clinical management of patients with chronic lymphocytic leukemia 

 

Faculty:

  • John Gribben (UK)
  • Carol Moreno (Spain)
  • Paolo Ghia (Italy)
  • Peter Hillmen (UK)

 

more info...

EM-59304
Highlights from EHA 2021: latest updates on multiple myeloma
22 June 2021 - 60 Minutes

Highlights from EHA 2021: latest updates on multiple myeloma

Learning objective:

After participating in this webinar, viewers should be able to:

  • Evaluate how recent data updates may impact the clinical management of patients with multiple myeloma 

 

Faculty:

  • Michel Delforge (Belgium)
  • Philippe Moreau (France)
  • Katja Weisel (Germany)

 

more info...

EM-59302
;